DrugPatentWatch Database Preview
SANCUSO Drug Profile
Try a free trial
See Plans and Pricing
When do Sancuso patents expire, and what generic alternatives are available?
Sancuso is a drug marketed by Kyowa Kirin and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.
This drug has forty patent family members in thirty-one countries.
The generic ingredient in SANCUSO is granisetron. There are twenty-six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the granisetron profile page.
Summary for SANCUSO
| International Patents: | 40 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 35 |
| Clinical Trials: | 15 |
| Patent Applications: | 4,404 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for SANCUSO |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for SANCUSO |
| DailyMed Link: | SANCUSO at DailyMed |
Pharmacology for SANCUSO
| Drug Class | Serotonin-3 Receptor Antagonist |
| Mechanism of Action | Serotonin 3 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for SANCUSO
Synonyms for SANCUSO
| 1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-indazole-3-carboxamide |
| 1-Methyl-N-(9-methyl-endo-9-azabicyclo(3.3.1)non-3-yl)-1H-indazole-3-carboxamide |
| 1-Methyl-N-[(1r,5s)-9-Methyl-9-Azabicyclo[3.3.1]nonan-3-Yl]indazole-3-Carboxamide |
| 1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]-3-indazolecarboxamide |
| 1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide |
| 1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-7-yl]indazole-3-carboxamide |
| 1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide |
| 107007-99-8 (mono-hydrochloride) |
| 109889-09-0 |
| 121061-98-1 |
| 124998-65-8 |
| 1H-Indazole-3-carboxamide, 1-methyl-N-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-, endo- |
| 3702AH |
| 889g090 |
| A802101 |
| AB00918713-07 |
| AB07494 |
| AC-8910 |
| AC1NR4P1 |
| AKOS025402424 |
| AN-7538 |
| APF 530 |
| APF530 |
| API0005490 |
| BDBM50443668 |
| BDBM50449636 |
| BIDD:GT0272 |
| BRL 43694 |
| BRL 43964 |
| BRL-43694 |
| C07023 |
| CCG-221158 |
| CHEBI:5537 |
| CHEBI:94501 |
| CHEMBL1290003 |
| D04370 |
| DB00889 |
| DL-166 |
| DTXSID0023111 |
| FT-0626805 |
| granisetron |
| Granisetron (JAN/USAN/INN) |
| Granisetron [USAN:INN:BAN:JAN] |
| Granisetronum |
| GTPL2300 |
| HMS2089P14 |
| HMS3715H17 |
| Kevatril |
| Kevatril|||1-Methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide, |
| Q-101870 |
| Sancuso (TN) |
| SCHEMBL34178 |
| SCHEMBL4890 |
| SCHEMBL4891 |
| SR-05000001492 |
| SR-05000001492-1 |
| SR-05000001492-2 |
| Sustol |
| UNII-WZG3J2MCOL |
| VA11035 |
| W-5139 |
| WZG3J2MCOL |
| ZINC100018852 |
| ZINC100018854 |
| ZINC347 |
US Patents and Regulatory Information for SANCUSO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kyowa Kirin | SANCUSO | granisetron | FILM, EXTENDED RELEASE;TRANSDERMAL | 022198-001 | Sep 12, 2008 | RX | Yes | Yes | Try a Free Trial | Try a Free Trial | Y | Try a Free Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for SANCUSO
| Drugname | Dosage | Strength | RLD | Date |
|---|---|---|---|---|
| ➤ Subscribe | Transdermal System | 3.1 mg/24 hrs | ➤ Subscribe | Try a Free Trial |
International Patents for SANCUSO
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2006516601 | Try a Free Trial |
| Canada | 2515094 | Try a Free Trial |
| European Patent Office | 1589956 | Try a Free Trial |
| Serbia | 20050600 | Try a Free Trial |
| Germany | 602004007888 | Try a Free Trial |
| >Country | >Patent Number | >Estimated Expiration |
